ArticlePhysiological reports2021

ω-Imidazolyl-alkyl derivatives as new preclinical drug candidates for treating non-alcoholic steatohepatitis.

Torsten Diesinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.